David M. Painter, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 322 Main St Fl 1, Bar Harbor, ME 04609 Phone: 207-288-5119 Fax: 207-288-8449 |
Ormanda Dorothea Johnson, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 322 Main St, Bar Harbor, ME 04609 Phone: 207-288-5119 Fax: 207-288-8449 |
Dr. Daniel Enrique Lomelin, MD, MPH Family Medicine Medicare: Medicare Enrolled Practice Location: 17 Hancock St, Bar Harbor, ME 04609 Phone: 207-288-5024 |
Dr. John Stephen Allerding, D.O Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 10 Wayman Ln, Bar Harbor, ME 04609 Phone: 207-288-5081 |
Mark A Kandutsch, M.D. Family Medicine - Sports Medicine Medicare: Accepting Medicare Assignments Practice Location: 322 Main St, Bar Harbor, ME 04609 Phone: 207-288-5081 Fax: 207-288-8449 |
Gabriel Johnson Plourde, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 322 Main St, Bar Harbor, ME 04609 Phone: 207-288-5119 Fax: 207-801-5801 |
Kathleen A Pelkey, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 600 Main St, Bar Harbor, ME 04609 Phone: 207-288-6096 Fax: 207-288-6443 |
Mr. Brian J. Caine, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 17 Hancock St, Bar Harbor, ME 04609 Phone: 207-288-5081 Fax: 207-288-8646 |
Oleg I Reznik, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Main St, Bldg 11, Bar Harbor, ME 04609 Phone: 207-288-1600 Fax: 207-288-1601 |
Vanessa Little, DO Family Medicine - Hospice and Palliative Medicine Medicare: Medicare Enrolled Practice Location: 10 Wayman Ln, Bar Harbor, ME 04609 Phone: 207-266-8303 |
Dr. Katherine Gassman, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 322 Main St, Bar Harbor, ME 04609 Phone: 207-288-5119 Fax: 207-801-5801 |
News Archive
Forest Laboratories, Inc. and Pierre Fabre Laboratories todayannounced that Forest has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for levomilnacipran, a serotonin norepinephrine reuptake inhibitor (SNRI) for the treatment of Major Depressive Disorder (MDD) in adults.
Ablative Solutions, Inc., a privately-held clinical stage company, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Peregrine System(TM) Infusion Catheter.
Large, for-profit dialysis facilities appear to administer higher than necessary amounts of a medication for treating anemia in patients with kidney disease, compared to nonprofit facilities, according to a study in the April 18 issue of JAMA.
Children who have been abused or exposed to other types of trauma typically experience more intense emotions than their peers, a byproduct of living in volatile, dangerous environments.
› Verified 3 days ago